Global Severe Asthma Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Severe Asthma Treatment Market Trends, Growth and Outlook 2025-31

The global Severe Asthma Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Severe Asthma Treatment Industry Forecast looks at past sales and reviews total world Severe Asthma Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Severe Asthma Treatment sales for 2025 through 2031. With Severe Asthma Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Severe Asthma Treatment industry. This Insight Report provides a comprehensive analysis of the global Severe Asthma Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Severe Asthma Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Severe Asthma Treatment market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Severe Asthma Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Severe Asthma Treatment. This report presents a comprehensive overview, market shares, and growth opportunities of Severe Asthma Treatment market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Oral &nbsp;&nbsp;&nbsp; lnhaled &nbsp;&nbsp;&nbsp; lntravenous &nbsp;&nbsp;&nbsp; Subcutaneous Segmentation by Application: &nbsp;&nbsp;&nbsp; Children &nbsp;&nbsp;&nbsp; Adults &nbsp;&nbsp;&nbsp; Teenagers This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Teva Pharmaceutical &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; GlaxoSmithKline &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Regeneron Pharmaceutical &nbsp;&nbsp;&nbsp; 4D Pharma plc &nbsp;&nbsp;&nbsp; AB Pharma &nbsp;&nbsp;&nbsp; Morphosys &nbsp;&nbsp;&nbsp; Roche &nbsp;&nbsp;&nbsp; Avalo Therapeutics &nbsp;&nbsp;&nbsp; Suzhou Connect Biopharmaceuticals &nbsp;&nbsp;&nbsp; Pieris Pharma &nbsp;&nbsp;&nbsp; Biosion Key Questions Addressed in this Report What is the 10-year outlook for the global Severe Asthma Treatment market? What factors are driving Severe Asthma Treatment market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Severe Asthma Treatment market opportunities vary by end market size? How does Severe Asthma Treatment break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Severe Asthma Treatment Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Severe Asthma Treatment by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Severe Asthma Treatment by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Severe Asthma Treatment Segment by Type &nbsp;2.2.1 Oral &nbsp;2.2.2 lnhaled &nbsp;2.2.3 lntravenous &nbsp;2.2.4 Subcutaneous &nbsp;2.3 Severe Asthma Treatment Sales by Type &nbsp;2.3.1 Global Severe Asthma Treatment Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Severe Asthma Treatment Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Severe Asthma Treatment Sale Price by Type (2020-2025) &nbsp;2.4 Severe Asthma Treatment Segment by Application &nbsp;2.4.1 Children &nbsp;2.4.2 Adults &nbsp;2.4.3 Teenagers &nbsp;2.5 Severe Asthma Treatment Sales by Application &nbsp;2.5.1 Global Severe Asthma Treatment Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Severe Asthma Treatment Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Severe Asthma Treatment Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Severe Asthma Treatment Breakdown Data by Company &nbsp;3.1.1 Global Severe Asthma Treatment Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Severe Asthma Treatment Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Severe Asthma Treatment Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Severe Asthma Treatment Revenue by Company (2020-2025) &nbsp;3.2.2 Global Severe Asthma Treatment Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Severe Asthma Treatment Sale Price by Company &nbsp;3.4 Key Manufacturers Severe Asthma Treatment Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Severe Asthma Treatment Product Location Distribution &nbsp;3.4.2 Players Severe Asthma Treatment Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Severe Asthma Treatment by Geographic Region &nbsp;4.1 World Historic Severe Asthma Treatment Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Severe Asthma Treatment Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Severe Asthma Treatment Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Severe Asthma Treatment Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Severe Asthma Treatment Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Severe Asthma Treatment Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Severe Asthma Treatment Sales Growth &nbsp;4.4 APAC Severe Asthma Treatment Sales Growth &nbsp;4.5 Europe Severe Asthma Treatment Sales Growth &nbsp;4.6 Middle East & Africa Severe Asthma Treatment Sales Growth 5 Americas &nbsp;5.1 Americas Severe Asthma Treatment Sales by Country &nbsp;5.1.1 Americas Severe Asthma Treatment Sales by Country (2020-2025) &nbsp;5.1.2 Americas Severe Asthma Treatment Revenue by Country (2020-2025) &nbsp;5.2 Americas Severe Asthma Treatment Sales by Type (2020-2025) &nbsp;5.3 Americas Severe Asthma Treatment Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Severe Asthma Treatment Sales by Region &nbsp;6.1.1 APAC Severe Asthma Treatment Sales by Region (2020-2025) &nbsp;6.1.2 APAC Severe Asthma Treatment Revenue by Region (2020-2025) &nbsp;6.2 APAC Severe Asthma Treatment Sales by Type (2020-2025) &nbsp;6.3 APAC Severe Asthma Treatment Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Severe Asthma Treatment by Country &nbsp;7.1.1 Europe Severe Asthma Treatment Sales by Country (2020-2025) &nbsp;7.1.2 Europe Severe Asthma Treatment Revenue by Country (2020-2025) &nbsp;7.2 Europe Severe Asthma Treatment Sales by Type (2020-2025) &nbsp;7.3 Europe Severe Asthma Treatment Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Severe Asthma Treatment by Country &nbsp;8.1.1 Middle East & Africa Severe Asthma Treatment Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Severe Asthma Treatment Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Severe Asthma Treatment Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Severe Asthma Treatment Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Severe Asthma Treatment &nbsp;10.3 Manufacturing Process Analysis of Severe Asthma Treatment &nbsp;10.4 Industry Chain Structure of Severe Asthma Treatment 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Severe Asthma Treatment Distributors &nbsp;11.3 Severe Asthma Treatment Customer 12 World Forecast Review for Severe Asthma Treatment by Geographic Region &nbsp;12.1 Global Severe Asthma Treatment Market Size Forecast by Region &nbsp;12.1.1 Global Severe Asthma Treatment Forecast by Region (2026-2031) &nbsp;12.1.2 Global Severe Asthma Treatment Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Severe Asthma Treatment Forecast by Type (2026-2031) &nbsp;12.7 Global Severe Asthma Treatment Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Teva Pharmaceutical &nbsp;13.1.1 Teva Pharmaceutical Company Information &nbsp;13.1.2 Teva Pharmaceutical Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.1.3 Teva Pharmaceutical Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Teva Pharmaceutical Main Business Overview &nbsp;13.1.5 Teva Pharmaceutical Latest Developments &nbsp;13.2 AstraZeneca &nbsp;13.2.1 AstraZeneca Company Information &nbsp;13.2.2 AstraZeneca Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.2.3 AstraZeneca Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 AstraZeneca Main Business Overview &nbsp;13.2.5 AstraZeneca Latest Developments &nbsp;13.3 GlaxoSmithKline &nbsp;13.3.1 GlaxoSmithKline Company Information &nbsp;13.3.2 GlaxoSmithKline Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.3.3 GlaxoSmithKline Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 GlaxoSmithKline Main Business Overview &nbsp;13.3.5 GlaxoSmithKline Latest Developments &nbsp;13.4 Novartis &nbsp;13.4.1 Novartis Company Information &nbsp;13.4.2 Novartis Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.4.3 Novartis Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Novartis Main Business Overview &nbsp;13.4.5 Novartis Latest Developments &nbsp;13.5 Sanofi &nbsp;13.5.1 Sanofi Company Information &nbsp;13.5.2 Sanofi Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.5.3 Sanofi Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Sanofi Main Business Overview &nbsp;13.5.5 Sanofi Latest Developments &nbsp;13.6 Regeneron Pharmaceutical &nbsp;13.6.1 Regeneron Pharmaceutical Company Information &nbsp;13.6.2 Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.6.3 Regeneron Pharmaceutical Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Regeneron Pharmaceutical Main Business Overview &nbsp;13.6.5 Regeneron Pharmaceutical Latest Developments &nbsp;13.7 4D Pharma plc &nbsp;13.7.1 4D Pharma plc Company Information &nbsp;13.7.2 4D Pharma plc Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.7.3 4D Pharma plc Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 4D Pharma plc Main Business Overview &nbsp;13.7.5 4D Pharma plc Latest Developments &nbsp;13.8 AB Pharma &nbsp;13.8.1 AB Pharma Company Information &nbsp;13.8.2 AB Pharma Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.8.3 AB Pharma Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 AB Pharma Main Business Overview &nbsp;13.8.5 AB Pharma Latest Developments &nbsp;13.9 Morphosys &nbsp;13.9.1 Morphosys Company Information &nbsp;13.9.2 Morphosys Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.9.3 Morphosys Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Morphosys Main Business Overview &nbsp;13.9.5 Morphosys Latest Developments &nbsp;13.10 Roche &nbsp;13.10.1 Roche Company Information &nbsp;13.10.2 Roche Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.10.3 Roche Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Roche Main Business Overview &nbsp;13.10.5 Roche Latest Developments &nbsp;13.11 Avalo Therapeutics &nbsp;13.11.1 Avalo Therapeutics Company Information &nbsp;13.11.2 Avalo Therapeutics Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.11.3 Avalo Therapeutics Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Avalo Therapeutics Main Business Overview &nbsp;13.11.5 Avalo Therapeutics Latest Developments &nbsp;13.12 Suzhou Connect Biopharmaceuticals &nbsp;13.12.1 Suzhou Connect Biopharmaceuticals Company Information &nbsp;13.12.2 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.12.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Suzhou Connect Biopharmaceuticals Main Business Overview &nbsp;13.12.5 Suzhou Connect Biopharmaceuticals Latest Developments &nbsp;13.13 Pieris Pharma &nbsp;13.13.1 Pieris Pharma Company Information &nbsp;13.13.2 Pieris Pharma Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.13.3 Pieris Pharma Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Pieris Pharma Main Business Overview &nbsp;13.13.5 Pieris Pharma Latest Developments &nbsp;13.14 Biosion &nbsp;13.14.1 Biosion Company Information &nbsp;13.14.2 Biosion Severe Asthma Treatment Product Portfolios and Specifications &nbsp;13.14.3 Biosion Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 Biosion Main Business Overview &nbsp;13.14.5 Biosion Latest Developments 14 Research Findings and Conclusion

Report	Global Severe Asthma Treatment Market Growth 2025-2031
Selected License	Multi ID: LPI39891

Buyer Information

Order Summary